Atripla
Active substance: efavirenz, emtricitabine, tenofovir disoproxil fumarate
efavirenz, emtricitabine, tenofovir disoproxil fumarate
Centralised EU authorisationWithdrawn
Marketing holder: Gilead Sciences Ireland UC
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 39 |
|
| US 18 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2e7a-7c2e-9d7a-756d95e7c3be,01a120c3-8406-73dc-ba79-4fbfa377cb56,01a120c3-8518-7826-80f4-7869128fc03b,01a120c3-8e49-7002-8d0e-2b27b1601444,01a120c3-98e7-7e36-b089-3e4c0a095af9;count=26 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-7a3e-7b7d-9516-920d22dcd8e1,01a1208d-7a5d-74aa-8938-49d947f0fded,01a12090-eb4d-7f8f-94a3-e92997d328ae,01a12094-3d05-733a-af00-3e3b5fdad356,01a12095-9298-799d-bb95-44b177a46082;count=8 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/000797
- Registration status
- Withdrawn
- ATC code
- J05AR06
- product · EMA · EMEA/H/C/000797 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000797 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000797 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/000797 · Verified 2026-10-09
- ingredients.2 · EMA · EMEA/H/C/000797 · Verified 2026-10-09